Samuel Hall is no longer serving in their board position at Stoke Therapeutics, Inc.
Jun 05, 2020
Board and Executive Moves
Director at Elstar Therapeutics, Inc.
In The News
Jun 05, 2020 - RelSci
Stoke Therapeutics Appoints Julie Anne Smith to its Board of Directors; Ms. Smith brings significant experience in biotech leadership and genetic diseases
Jun 04, 2020 - Business Wire
Jan 07, 2019 - peHUB
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
In The News
Stoke Therapeutics Presents New Data That Demonstrate Tango Antisense Oligonucleotides (ASOs) Increase OPA1 Protein Production and Improve Mitochondrial Function in Cells Derived From Patients With Autosomal Dominant Optic Atrophy (ADOA); - Results presen
May 04, 2021 - Business Wire
Mar 24, 2021 - Business Wire
Monday March 22, 2021 Antibe Therapeutics (ATE:CAD5.44) lifts 3.4% strengthening above moving average price, hits 26-day high
Mar 22, 2021 - News Bites Canadian Markets